eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hodgkin lymphoma |
| Comorbidity | C0079731|b-cell non-hodgkin lymphoma |
| Sentences | 14 |
| PubMedID- 22355706 | Dlbcl is the most common b-cell non-hodgkin lymphoma in adults, accounting for ≈40% of all new lymphoma diagnoses. |
| PubMedID- 23982056 | B-cell non-hodgkin lymphoma (b-nhl), a potential late complication of cryoglobulinemia, occurred in both groups of patients. |
| PubMedID- 25623859 | Diffuse large b-cell lymphoma (dlbcl) is one of the most common types of aggressive b-cell non-hodgkin lymphoma (b-nhl) and accounts for about 31% of adult b-nhls in western countries [1]. |
| PubMedID- 23028738 | The b-cell non-hodgkin lymphoma cell lines su-dhl-6 and su-dhl-8, purchased from dsmz (german collection of microorganisms and cell cultures, braunschweig, ger), were cultivated in rpmi 1640 supplemented with 10% fcs and 1% pen strep. |
| PubMedID- 26045130 | Mantle cell lymphoma (mcl) is an uncommon b-cell non-hodgkin lymphoma, comprising approximately 6-8% of all non-hodgkin lymphomas. |
| PubMedID- 22174855 | B-cell non-hodgkin lymphomas (nhl) are common lymphoid malignancies in which malignant b cells arrested at varying stages of differentiation often involve lymph nodes (lns) and occasionally extranodal tissues. |
| PubMedID- 21359853 | [4] is an aggressive variant of diffuse large b-cell non-hodgkin lymphoma seen predominantly in a setting of aids and nearly always in extranodal sites. |
| PubMedID- 20482846 | Twenty-six cases of b-cell non-hodgkin lymphoma diagnosed by hematopathologists from department of pathology, faculty of medicine siriraj hospital, mahidol university, were enrolled in this study. |
| PubMedID- 24434689 | Endemic burkitt lymphoma (ebl) is a monoclonal b-cell non-hodgkin lymphoma that is common in equatorial africa and papua new guinea, which has been linked to childhood infection with plasmodium falciparum (pf)1234, a class 2a carcinogen for ebl5. |
| PubMedID- 20454499 | Samples from the adrenocortical tumor and b-cell non-hodgkin lymphoma were analyzed with the aip-flanking microsatellite marker d11s1258, and loh was confirmed in the adrenocortical tumor (figure 3b). |
| PubMedID- 21712948 | Mucosa-associated lymphoid tissue (malt) lymphoma is a b-cell non-hodgkin lymphoma arising in lymphoid infiltrates at extranodal sites [1]. |
| PubMedID- 23311295 | Beacopp escalated and rituximab in the treatment of hodgkin lymphoma occurring concurrently with diffuse large b-cell non-hodgkin lymphoma. |
| PubMedID- 21390126 | Diffuse large b-cell lymphoma (dlbcl) represents the most common form of b-cell non-hodgkin lymphoma (b-nhl), accounting for ~30% of the de-novo diagnoses and also arising as a frequent clinical evolution of follicular lymphoma (fl)1. the molecular pathogenesis of dlbcl is associated with multiple genetic lesions that segregate in part with individual phenotypic subtypes, namely germinal-center b-cell-like (gcb) and activated b-cell-like (abc) dlbcl, suggesting the involvement of distinct oncogenic pathways2–8. |
| PubMedID- 22919406 | Besides its hepatotropic characteristics, hcv is also a lymphotropic virus [2, 3] responsible for hcv-related b-cell non-hodgkin lymphoma (nhl) [4–6], immune-mediated extrahepatic manifestations, mixed cryoglobulinaemic vasculitis [7–12], and the presence in serum of rheumatoid factor and autoantibodies [13–15]. |
Page: 1